Compare TNYA & JILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNYA | JILL |
|---|---|---|
| Founded | 2016 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 178.5M | 188.7M |
| IPO Year | 2021 | 2017 |
| Metric | TNYA | JILL |
|---|---|---|
| Price | $0.99 | $13.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | $5.33 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 3.3M | 55.2K |
| Earning Date | 05-07-2026 | 06-10-2026 |
| Dividend Yield | N/A | ★ 2.42% |
| EPS Growth | ★ 54.96 | N/A |
| EPS | N/A | ★ 1.82 |
| Revenue | N/A | ★ $596,549,000.00 |
| Revenue This Year | N/A | $2.65 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.01 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.36 | $10.41 |
| 52 Week High | $2.35 | $18.80 |
| Indicator | TNYA | JILL |
|---|---|---|
| Relative Strength Index (RSI) | 70.17 | 55.63 |
| Support Level | $0.65 | $10.41 |
| Resistance Level | $1.04 | $13.55 |
| Average True Range (ATR) | 0.06 | 0.62 |
| MACD | 0.03 | 0.14 |
| Stochastic Oscillator | 96.17 | 89.37 |
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). J.Jill caters to a distinctive set of women, typically forty-five years and older, offering them various apparel products, footwear, and accessories, comprising shirts, dresses, tops and tees, sweaters, pants and jeans, jewelry, bags, belts, shoes, scarves, etc. The company's operating segments consist of its Retail channels, which derive maximum revenue, and Direct channels. Geographically, the majority of its revenue is derived from the United States.